These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Nitrogranulogen therapy of allergic diseases of the gastrointestinal system]. MIGDAĆ A Pol Tyg Lek (Wars); 1954 Mar; 9(12):362-6. PubMed ID: 13224393 [No Abstract] [Full Text] [Related]
4. Treatment of asthma with nitrogen mustard; observations of the nature of allergic diseases and treatment of dysreaction. JIMENEZ DIAZ C; MERCHANTE A; PERIANES J; LAHOZ C; BARRANTES VL Bull Inst Med Res Univ Madr; 1952; 5(2):73-82. PubMed ID: 12997906 [No Abstract] [Full Text] [Related]
5. Shwartzman phenomenon. III. Modifications of nitrogen-mustard suppression. SCHLANG HA Proc Soc Exp Biol Med; 1952 Oct; 81(1):274-7. PubMed ID: 13047381 [No Abstract] [Full Text] [Related]
6. [Effect of nitrogen mustard (methyl-bis-beta-chloroethyl amine hydrochloride) on passive cutaneous anaphylaxis in the guinea pig]. CORELLI F; OVARY Z Boll Soc Ital Biol Sper; 1951 Dec; 27(12):1677-9. PubMed ID: 14934918 [No Abstract] [Full Text] [Related]
7. Arthus phenomenon-like skin reaction caused by vaccinia virus with special reference to effect of nitrogen mustard and benzene. MIYAZAKI Y; IIDA T; OW S Jpn J Microbiol; 1957 Oct; 1(4):393-405. PubMed ID: 13562974 [No Abstract] [Full Text] [Related]
9. [Clinical toxicology of nitrogen mustards]. SCHMIDT L; SCHENNETTEN F Z Gesamte Inn Med; 1956 May; 11(10):477-80. PubMed ID: 13353313 [No Abstract] [Full Text] [Related]
10. Bone marrow protection in mechlorethamine (nitrogen mustard) therapy. MILLER DG; LAWRENCE W Arch Surg; 1962 Sep; 85():430-41. PubMed ID: 14473972 [No Abstract] [Full Text] [Related]
11. Experiments on the therapeutic index of nitrogen mustard (HN2). WHITE LP Acta Unio Int Contra Cancrum; 1960; 16():800-6. PubMed ID: 13844375 [No Abstract] [Full Text] [Related]
12. Toxicological and clinical evaluation of a new nitrogen mustard, 2-[di-2(chloroethyl)-aminomethyl]benzimidazole. ULTMANN JE; THOMPSON HG; HIRSCHBERG E; ZAIDENWEBER J; GELLHORN A Cancer Res; 1959 Aug; 19():719-25. PubMed ID: 13855167 [No Abstract] [Full Text] [Related]
13. Chromosome damage during nitrogen mustard therapy. A case report. CONEN PE; LANSKY GS Br Med J; 1961 Oct; 2(5259):1055-7. PubMed ID: 13880833 [No Abstract] [Full Text] [Related]
14. [On the experimental production of phocomeli in the chick embryo using nitrogen mustard]. SALZGEBER B C R Hebd Seances Acad Sci; 1962 May; 254():3591-3. PubMed ID: 14496542 [No Abstract] [Full Text] [Related]
15. Protection against systemic toxicity due to nitrogen mustard. ROSS CA; CAR BERRY DM; KRAUS GE Surg Forum; 1960; 11():43-5. PubMed ID: 13743580 [No Abstract] [Full Text] [Related]
16. Shwartzman phenomenon. II. Suppressive action of HN2 on antigen-antibody provocation. SCHLANG HA Proc Soc Exp Biol Med; 1952 Apr; 79(4):639-40. PubMed ID: 14920519 [No Abstract] [Full Text] [Related]
17. Complications following pelvic perfusion with nitrogen mustard for cancer. SHOLES DM; JENKINS HH J Tn State Med Assoc; 1960 Apr; 53():134-9. PubMed ID: 14446152 [No Abstract] [Full Text] [Related]
18. A comparison between the hematological side effects of cyclophosphamide and nitrogen mustard. NISSEN-MEYER R; HOST H Cancer Chemother Rep; 1960 Nov; 9():51-5. PubMed ID: 13729268 [No Abstract] [Full Text] [Related]
19. Influence of pH on the toxicity of nitrogen mustard. WHITE LP Science; 1960 Apr; 131(3406):1041-3. PubMed ID: 13844376 [TBL] [Abstract][Full Text] [Related]
20. Thiosulfate protection against the toxic effects of nitrogen mustard in perfusion of the liver. FOSTER JH; LEWIS MR; JACOBS JK Am Surg; 1962 Jul; 28():461-4. PubMed ID: 13894237 [No Abstract] [Full Text] [Related] [Next] [New Search]